The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
Recruiting · NCT07250100 · Observational (researchers observe without assigning treatment) · Lead sponsor: Herlev Hospital
View the official record on ClinicalTrials.gov →Interventions studied
observational study
What this trial is about
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response. Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with a suspected lesion (solid/cystic) in the pancreas undergoing diagnostic or therapeutic endoscopic procedure
- Age of 18 years or above
- Signed informed consent form
Exclusion criteria
- Contraindications for endoscopic or surgical procedure, such as uncorrected coagulopathy
Where it is running
1 location listed.
- Herlev og Gentofte Hospital - Herlev, Capital Region, Denmark